SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
Clin. transl. oncol. (Print)
; 23(5): 931-939, mayo 2021. tab, ilus
Artigo
em Inglês
| IBECS
| ID: ibc-221233
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Transfusão de Sangue
/
Ferro da Dieta
/
Suplementos Nutricionais
/
Anemia
/
Neoplasias
Limite:
Humanos
País/Região como assunto:
Europa
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2021
Tipo de documento:
Artigo
Instituição/País de afiliação:
Clínica Universidad de Navarra/Spain
/
Consorcio Hospital General Universitario/Spain
/
Consorcio Hospitalario Provincial de Castellón/Spain
/
Hospital General Universitario Gregorio Marañón/Spain
/
Hospital Universitario Puerta del Mar/Spain
/
Hospital Universitario Virgen de la Arrixaca/Spain
/
Hospital Universitario de Jerez de la Frontera/Spain
/
Hospital Virgen de Los Lirios/Spain
/
Hospitalario Clínico Universitario de Santiago/Spain